文献速递临床试验与 GCP真实世界研究与卫生经济

使用移动健康干预减少2型糖尿病患者职业性久坐行为的健康影响:一项为期12个月随机对照试验的研究方案——ROSEBUD研究

Health effects of reduced occupational sedentary behaviour in type 2 diabetes using a mobile health intervention: a study protocol for a 12-month randomized controlled trial-the ROSEBUD study.
PubMed 文献 · Trials · 2022-07-27

本方案描述一项在瑞典五个地区初级卫生保健中心开展的双臂、为期12个月随机对照试验,计划纳入142名以久坐工作为主的2型糖尿病成人。参与者按1:1随机分为移动健康干预组(活动追踪腕带、定期短信提醒和糖尿病专科护士咨询)或对照组(仅糖尿病专科护士咨询),主要结局为设备测量的总久坐时间和总步数。

要点

  • 纳入142名以久坐工作为主的2型糖尿病成人,按1:1随机分组。
  • 干预组接受活动追踪腕带、短信提醒和糖尿病专科护士咨询,对照组仅接受护士咨询。
  • 主要结局为设备测量的总久坐时间和总步数,随访12个月。

核心结论

  • 该12个月随机对照试验将评估适用于真实世界初级卫生保健环境的移动健康干预的长期效果。

研究设计与样本

  • 在瑞典五个地区初级卫生保健中心开展的双臂、为期12个月随机对照试验,计划纳入142名以久坐工作为主的2型糖尿病成人,按1:1随机分组。
  • 干预组接受活动追踪腕带(Garmin Vivofit4)、定期短信提醒和糖尿病专科护士咨询;对照组仅接受糖尿病专科护士咨询。
  • 主要结局为设备测量的总久坐时间和总步数(activPAL3)。

主要发现

  • 原文未报告结果,本方案仅描述研究设计与目的。

关键数值与推荐

  • 主要结局为设备测量的总久坐时间和总步数(activPAL3)。
  • 次要结局包括疲劳、健康相关生活质量、肌肉骨骼问题(自报问卷)、病假天数(日记)、糖尿病药物(临床记录审查)以及 cardiometabolic 生物标志物(腰围、平均血压、HbA1c、HDL胆固醇和甘油三酯)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Short-term trials conducted in adults with type 2 diabetes mellitus (T2DM) showed that reducing sedentary behaviour by performing regular short bouts of light-intensity physical activity enhances health. Moreover, support for reducing sedentary behaviour may be provided at a low cost via mobile health technology (mHealth). There are a wide range of mHealth solutions available including SMS text message reminders and activity trackers that monitor the physical activity level and notify the user of prolonged sitting periods. The aim of this study is to evaluate the effects of a mHealth intervention on sedentary behaviour and physical activity and the associated changes in health in adults with T2DM. METHODS: A dual-arm, 12-month, randomized controlled trial (RCT) will be conducted within a nationwide Swedish collaboration for diabetes research in primary health care. Individuals with T2DM (n = 142) and mainly sedentary work will be recruited across primary health care centres in five regions in Sweden. Participants will be randomized (1:1) into two groups. A mHealth intervention group who will receive an activity tracker wristband (Garmin Vivofit4), regular SMS text message reminders, and counselling with a diabetes specialist nurse, or a comparator group who will receive counselling with a diabetes specialist nurse only. The primary outcomes are device-measured total sitting time and total number of steps (activPAL3). The secondary outcomes are fatigue, health-related quality of life and musculoskeletal problems (self-reported questionnaires), number of sick leave days (diaries), diabetes medications (clinical record review) and cardiometabolic biomarkers including waist circumference, mean blood pressure, HbA1c, HDL-cholesterol and triglycerides. DISCUSSION: Successful interventions to increase physical activity among those with T2DM have been costly and long-term effectiveness remains uncertain. The use of mHealth technologies such as activity trackers and SMS text reminders may increase awareness of prolonged sedentary behaviour and encourage increase in regular physical activity. mHealth may, therefore, provide a valuable and novel tool to improve health outcomes and clinical management in those with T2DM. This 12-month RCT will evaluate longer-term effects of a mHealth intervention suitable for real-world primary health care settings. TRIAL REGISTRATION: ClinicalTrials.gov NCT04219800 . Registered on 7 January 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Syrjälä MB, Bennet L, Dempsey PC, et al. Health effects of reduced occupational sedentary behaviour in type 2 diabetes using a mobile health intervention: a study protocol for a 12-month randomized controlled trial-the ROSEBUD study. Trials. 2022. PMID: 35897022. doi:10.1186/s13063-022-06528-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。